In Vitro Susceptibilities of Gram-Negative Bacteria Isolated from Hospitalized Patients in Four European Countries, Canada, and the United States in 2000-2001 to Expanded-Spectrum Cephalosporins and Comparator Antimicrobials: Implications for Therapy
暂无分享,去创建一个
[1] J. Karlowsky,et al. Antibiotic resistance - is resistance detected by surveillance relevant to predicting resistance in the clinical setting? , 2002, Current opinion in pharmacology.
[2] D. Livermore,et al. Trends in Fluoroquinolone (Ciprofloxacin) Resistance in Enterobacteriaceae from Bacteremias, England and Wales, 1990–1999 , 2002, Emerging infectious diseases.
[3] J. Karlowsky,et al. Ceftriaxone activity against Gram-positive and Gram-negative pathogens isolated in US clinical microbiology laboratories from 1996 to 2000: results from The Surveillance Network (TSN) Database-USA. , 2002, International journal of antimicrobial agents.
[4] R. Wenzel,et al. The impact of hospital-acquired bloodstream infections. , 2001, Emerging infectious diseases.
[5] J. Karlowsky,et al. Evaluation of Current Activities of Fluoroquinolones against Gram-Negative Bacilli Using Centralized In Vitro Testing and Electronic Surveillance , 2001, Antimicrobial Agents and Chemotherapy.
[6] M. Ferraro. Performance standards for antimicrobial susceptibility testing , 2001 .
[7] F. Raffi,et al. Impact of fluoroquinolone administration on the emergence of fluoroquinolone-resistant gram-negative bacilli from gastrointestinal flora. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[8] G Sherman,et al. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. , 2000, Chest.
[9] J. Verhoef,et al. Antimicrobial susceptibility and frequency of occurrence of clinical blood isolates in Europe from the SENTRY antimicrobial surveillance program, 1997 and 1998. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[10] M. Pfaller,et al. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group. , 2000, International journal of antimicrobial agents.
[11] M. Pfaller,et al. Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[12] L. Elting,et al. Susceptibility Surveillance among Gram-Negative Bacilli at a Cancer Center , 1999, Chemotherapy.
[13] A. Schaeffer,et al. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Infectious Diseases Society of America (IDSA). , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[14] M. Marsilio,et al. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with the Surveillance Network Database--USA. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] D. McClish,et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[16] R A Weinstein,et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. , 1999, JAMA.
[17] R. Wenzel. Perspective: Attributable mortality--the promise of better antimicrobial therapy. , 1998, The Journal of infectious diseases.
[18] J. D. Williams. 1996 Report of the Comité de l'Antibiogramme de la Société Française de Microbiologie. , 1997, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[19] L. Mandell,et al. Hospital-acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: A consensus statement , 1996 .
[20] J. Ariza,et al. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections , 1995, Antimicrobial agents and chemotherapy.
[21] E. P. Dellinger,et al. Quality Standard for the Treatment of Bacteremia , 1994, Infection Control & Hospital Epidemiology.
[22] P. M. Terry,et al. Rapid development of ciprofloxacin resistance in methicillin-susceptible and -resistant Staphylococcus aureus. , 1991, The Journal of infectious diseases.
[23] F. Goldstein,et al. Communiqué 1992 du comité de l'antibiogramme de la société française de microbiologie , 1990 .
[24] R. Dixon,et al. Nosocomial Respiratory Infections , 1983, Infection Control.
[25] E. Bruck,et al. National Committee for Clinical Laboratory Standards. , 1980, Pediatrics.
[26] John E. Bennett,et al. Principles and practice of infectious diseases. Vols 1 and 2. , 1979 .
[27] S TschudiMadsen,et al. Nosocomial urinary tract infections , 1972 .